Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-19-021844
Filing Date
2019-04-17
Accepted
2019-04-17 09:17:29
Documents
1
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 S-8 POS a19-8251_6s8pos.htm S-8 POS 31830
  Complete submission text file 0001104659-19-021844.txt   32837
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

EIN.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-167652 | Film No.: 19752310
SIC: 2836 Biological Products, (No Diagnostic Substances)